Biotech, Pharma Stocks Surge as IPAB Not Triggered
As noted earlier, biotech and pharmaceutical stocks surged higher mid-day on news the Medicare IPAB cost panel was not triggered this year, pushing it into 2017.
Related Stocks:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baxter (BAX) sees early weakness
- AI bubble about to burst? Not yet, Yardeni says
- EQT nears €9.6 billion deal to acquire Qiagen - Bloomberg
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share